Siemens Healthineers at SNMMI 2018
Expanding precision medicine with molecular imaging
View our innovations at SNMMI 2018, visit booth #643 to see live demos.
- Accuracy to reveal the bigger picture
- Performance to maximize efficiency
- Reproducibility to understand disease progression better
Biograph Horizon Flow edition
The new Biograph HorizonTM Flow2 edition with FlowMotionTM technology enables standardized indication-based protocols, adjusted to the patients anatomy, all in a single scan.
Biograph mCT Flow
Biograph mCT Flow with FlowMotion technology combines our standard-setting PET/CT with a unique system design that enables continuous motion of the patient table—allowing increased image quality, greater patient comfort, better performance and expanded versatility.
FlowMotion continuous bed motion technology, enables standardized indication-based protocols, adjusted to the patient’s anatomy, all in a single scan–personalizing the patient experience while optimizing the workflow.
With Biograph mMR MR/PET you can set the pace in diagnostic imaging, by combining leading 3T MRI performance with proven molecular imaging, fully integrated in one system.
Symbia Intevo Bold
For quick and conclusive answers to clinical questions, you need the best image for each patient. This often means achieving a careful balance between image quality and radiation dose. But with a more diverse patient population and a growing concern over radiation risk, striking this balance can be a challenge. To help you accomplish this, we combined high-performance CT with our proven SPECT technologies. Look no further than Symbia Intevo Bold.TM1
Priorities in healthcare are shifting. Better care no longer means more care. It means more effective care. Now, you can discover expanded clinical reach and a higher standard of care and distinction for your organization−with the hybrid SPECT/CT technology of Symbia Intevo.TM2
Expanded xSPECT QuantTM2 now offers automated, accurate and reproducible quantification of 99mTc, 123I, 177Lu and 111In. This extends the use of advanced SPECT/CT quantification from general nuclear medicine and bone studies to indications including neurological disorders, neuroendocrine tumors, neuroblastoma and metastatic prostate cancer. xSPECT BoneTM2 provides higher resolution and increased clinical detail to support physicians’ ability to more confidently characterize disease state. xSPECT,TM2 the true integration of SPECT and CT.
syngo.via for MI
Save time, cost and effort with one reading solution engineered for greater productivity and accuracy: syngo®.via for Molecular Imaging is available for both PET/CT, SPECT and SPECT/CT.
PETNET Solutions Inc. a Siemens Healthineers Company
PETNET Solutions support the growth of our customers’ business with one-time delivery of PET tracers and comprehensive value-added services.
1Biograph Vision and its features and applications and are currently under development and are not for sale in the U.S. Their future availability cannot be guaranteed. They do not yet fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations and are not yet commercially available in the European Union.
2Biograph Horizon Flow edition, Biograph mCT Flow, Symbia Intevo, Symbia Intevo Bold, xSPECT, xSPECT Bone and xSPECT Quant are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.